◆ 会议时间：2025年6月3-6日
◆ 会议地点：英国 格拉斯哥

◆ 会议简介：

2025年欧洲变态反应与临床免疫学会(EAACI)大会/年会将于2025年6月3-6日在英国 格拉斯哥举行。欧洲过敏与临床免疫学会大会(EAACI年会)是世界上最大和最具影响力的过敏、哮喘和临床免疫学会议，每年的EACCI大会都会吸引来自世界各地的近8000名专业人士与会（2019年会议与会人数8733人）。EACCI年会主题涵盖过敏性疾病和哮喘领域的各个方面，为过敏学家、肺病学家、 耳鼻喉科医师、皮肤科医生、内科医生、儿科医生、胃肠病学家、临床免疫学家和初级保健医师提供了一个了解最新的发现、互相交流学习及建立社交网络的多学科论坛。

欧洲变态反应与临床免疫学会(EACCI)成立于1956年，是一个活跃在过敏性和免疫性疾病领域（如哮喘，鼻炎，湿疹，职业过敏，食物和药物过敏和过敏反应）的非营利组织，致力于宣改善受过敏性疾病所影响的人们的健康。EACCI现已发展成为欧洲变态反应与临床免疫学领域最大的医学协会，现拥有来自121个国家的9500多名个人成员和52个国家学会成员，包括临床医生、研究人员和联合卫生专业人员等；EACCI是欧洲过敏症方面专业知识的主要来源。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)

EAACI Congress 2025
European Academy of Allergy & Clinical Immunology Annual Congress

Date: 3 - 6 June 2025
Place: Glasgow, UK

The EAACI Annual Congress is the flagship meeting of the academy and the world’s largest congress specialising in the field of allergy and clinical immunology. A wide range of sessions, including interactive formats, provide optimal learning for all tastes. Attracting in the region of 7000-8000 participants and experts from across the globe, the congress is a key annual event to interact with peers, leading scientists and practitioners over five days,lingyuint. The Scientific Programme will present the best in science and educational sessions from distinguished researchers from across the globe. Covering key topics in allergic diseases and asthma the EAACI Annual Congress provides a multidisciplinary forum for allergists, pulmonologists, ENTs, dermatologists, internists, pediatricians, gastroenterologists, clinical immunologists and primary care physicians.

以下为上届会议信息

摘要征文投稿：

Abstract Submission
DEADLINE: MONDAY 15 JANUARY 2024 at 23:59 CET

点此提交摘要>>>Submit Abstract>>>

Abstract Submission – Guidelines

Abstract Submission – Terms & Conditions

Instructions to authors

Carefully read the guidelines before submitting your abstract, find the guidelines here.

IMPORTANT NOTES:

• Except for E-Poster Display Only, all abstracts must be presented onsite at the Congress during the dedicated session. No digital presentations are foreseen.
• If EAACI does not receive your registration and payment by the given deadline, your abstract will be removed from the programme.
• The presenting author must be registered using the same email address which was indicated during the abstract submission.

Submission:

• When entering the abstract submission system for the first time, you will be asked to create a MyEAACI account (if you don’t have one already). Through your MyEAACI account you will be able to access your personal page to submit one or several abstracts.
• Upon submission, a confirmation email will be sent to the submitter’s email address. If you do not receive the confirmation e-mail, please do not submit the abstract again. Instead, please contact the Scientific Secretariat abstract@eaaci.org for advice.
• Declaration of conflict of interest: EAACI is committed to ensuring the integrity of scientific, educational, and research programmes. Abstract submission requires disclosure of any financial or other interest that might be construed as resulting in an actual, potential, or apparent conflict. The submitter is responsible for obtaining disclosure information from all co-authors, to be entered in the author section of the submission page.
• IMPORTANT! The presenting author must be registered using the same email address which was indicated during the abstract submission.

Abstract format and content:

• Abstracts and presentations must be written in
• The maximum length allowed for an abstract is 2500 characters (approximately 350 words) including blank spaces. The abstract title, the author(s) or names of institutions are not included in the count of 2500 characters.
• Consent for publication of individual patient data: For abstracts with identifiable patient details (e.g. gender, age, illness, location) or images, it is the author’s responsibility to obtain written informed consent for publication of clinical details and/or clinical images from the patient/parent/guardian/relative of the patient. A respective statement needs to be included in the abstract text.
• Unpublished abstracts that have been presented at a different scientific meeting within a 12 months period prior to EAACI Hybrid Congress 2024, provided they contain updated/additional data, can be submitted and will be considered for presentation.

Abstracts submitted for publication or to a scientific meeting, but are pending acceptance, can be submitted without restrictions. However, once the abstract has been accepted by EAACI it is automatically subject to the EAACI embargo policy.

Edit, withdrawal, change of presenter:

• You can edit your abstracts until the submission deadline on Monday 15 January 2024, 23:59 CET.If you need withdraw your abstract, a written statement listing the reasons for this decision must be sent to the EAACI Scientific Secretariat no later than 28 March 2024 (abstract@eaaci.org). Withdrawals after this date cannot be accepted.
• All presenter changes can only be processed until 18 April 2024 and must be addressed to abstract@eaaci.org.

Notification of acceptance:

• Notifications of acceptance of the abstracts will be sent to the presenting author of the abstract by mid March 2024.

Registration and publication:

• The presenting author of an abstract must register for the onsite Until 28 March 2024 the presenting author is offered a special extended “early fee”.
• Accepted abstracts will be published in the online programme, EAACI website and EAACI content platform during the Congress. Publication of the abstracts as a supplement in the Allergy Journal will be done after the congress. Please note that your abstract will only be published in the Allergy journal if the abstract is accepted, uploaded/presented, and the presenting author is registered using the same email address used for abstract submission. In order to have your abstract published on the website you need to be registered for the congress by 28 March 2024.
• All abstracts selected for E-TPS Display Only will NOT be published on the EAACI content platform nor in the Allergy Journal.

注册费：

Check your physical registration options

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。